TITLE

Biotechnology News Round-up

PUB. DATE
December 2003
SOURCE
PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p2
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Reports on developments related to the biotechnology industry in the U.S. as of December 2003. Efficacy of the drug ETC-216 of Esperion Therapeutics Inc.; Deal entered by AstraZeneca PLC with Abgenix Inc.; Agreement of Cephalon Inc. to acquire Cima Labs Inc.
ACCESSION #
13840218

 

Related Articles

  • Licensing News Headlines October 15, 2003 - November 14, 2003.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p16 

    Reports on developments related to the biotechnology industry in the U.S. from October 15 to November 14, 2003. Acquisition by Titan Pharmaceuticals Inc. of a novel product in clinical testing for the treatment of congestive heart failure; License granted to Vertex Pharmaceuticals Inc. from...

  • Cephalon to acquire Cima Labs for $515 million.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p22 

    Reports on the plan of Cephalon Inc. to acquire Cima Labs Inc. in the U.S. Value of deal; Terms under the planned acquisition; Benefits of the acquisition for both companies.

  • AstraZeneca invests $100 million into oncology alliance with Abgenix.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p17 

    Reports on the investment made by AstraZeneca PLC with Abgenix Inc. to develop fully human monoclonal antibodies to treat cancer. Plans of companies under their operations; Benefits of the investment for parties involved; Significance of the investment and agreement for the pharmaceutical...

  • Cima Leaves aaiPharma for Cephalon.  // Chemical Market Reporter;11/10/2003, Vol. 264 Issue 16, p2 

    Reports on the ownership and control of the drug delivery technology platform, Cima Labs Inc. won by drug company, Cephalon Inc. over aaiPharma Inc. Terms and details of the stock purchase; Operations and financial performance of the companies; Stock price.

  • Impax Laboratories initiates patent challenge relating to Generic Fentora.  // PharmaWatch: CNS;Jan2012, Vol. 11 Issue 1, p14 

    The article reports that Cephalon Inc. and CIMA Labs Inc. have filed a lawsuit against Impax Laboratories Inc. on November 18, 2011 for patent infringement with regards to the company's Fentora or fentanyl buccal tablets.

  • Esperion's ETC-216 proves effective in reversing atherosclerosis.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p8 

    Reports on the result of the clinical study on ETC-216, a drug candidate developed by Esperion Therapeutics. Presentation of the clinical study of ETC-216; Description of ETC-216; Patients enrolled in the study.

  • Abgenix and Amgen clarify responsibilities for ABX-EGF.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p17 

    Reports that Abgenix Inc. and Immunex Corp. has amended their agreement pertaining the development and commercialization of a fully human monoclonal antibody, ABX-EGF. Terms under the amended agreement; Benefits of the agreement for parties involved; Significance of the agreement for the...

  • Esperion hunts biotech bargains. Henderson, Tom // Crain's Detroit Business;2/2/2009, Vol. 25 Issue 5, p1 

    The article reports that Esperion Therapeutics Inc. has begun growing tissue culture in its new laboratory in Plymouth Township, Michigan. This is reportedly an important step for one of the most successful biotechs in state history as it continues its reinvention and takes aim at creating what...

  • Pharmaceuticals firm to bring up to 85 new jobs to Salt Lake City. Shelton, Ryan // Enterprise/Salt Lake City;6/1/2009, Vol. 38 Issue 49, p1 

    The article reports on the decision of Cephalon Inc., a pharmaceutical company based in Frazer, Pennsylvania, to relocate its subsidiary, CIMA Labs in Brooklyn Park, Minnesota to Salt Lake City, Utah. In line with the planned relocation, Cephalon has commenced the construction of the facility...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics